Dr. Yan Leyfman on Advancing cancer research, transforming patient care and surviving Chernobyl
In this episode of OncoDaily, hosted by Emma Ter-Azaryan, Dr. Yan Leyfman, Co-Founder and Executive Director of MedNews Week — shares his extraordinary journey from surviving the effects of the Chernobyl disaster to becoming a global leader in oncology and scientific strategy. Diagnosed with health complications early in life due to radiation exposure, Dr. Leyfman opens up about the pivotal moments that shaped his path toward medicine. He details how personal tragedy, scientific passion, and relentless dedication led him to the frontlines of the COVID-19 response and precision oncology research.
Dr. Leyfman discusses:
- Surviving Chernobyl and its impact on his medical journey
- Leading COVID-19 scientific efforts globally
- Breakthroughs in immunotherapy and precision oncology
- Founding MedNews Week to bridge science and the public
- Advocating for health equity and innovation in cancer care
00:00 Introduction
02:37 Dr. Leyfman’s personal story: Surviving the Chernobyl disaster
05:50 How the effects of radiation exposure shaped his path in medicine
09:15 Transitioning from a personal tragedy to a career in oncology
16:45 Leading COVID-19 scientific efforts and the global response
21:13 Breakthroughs in immunotherapy and precision oncology
26:30 The founding of MedNewsWeek and its impact on science communication
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023